Skip to content

Establishment of a multi-dimensional assessment system and risk prediction model for immune senescence in the elderly population in China.

Establishment of a multi-dimensional assessment system and risk prediction model for immune senescence in the elderly population in China.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127968
Enrollment
Unknown
Registered
2026-07-10
Start date
2025-02-27
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Sepsis group:none

Sponsors

The First Affiliated Hospital, Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: 18 years and above. 2. Gender: No restrictions. 3. Disease diagnosis: (1) Sepsis patient group: 1) Meet the international definitions of sepsis and septic shock (Sepsis-3). 2) Temperature >38°C or 90 beats/min 4) Respiratory rate >22/min or PaCO2 12×10^9/L or 10% (2) Non-sepsis patient group: 1) Critically ill patients without sepsis. 2) Do not meet the above sepsis diagnostic criteria. 4. Admission time: Within 24 hours of ICU admission. 5. Medical history and treatment: (1) No severe heart, liver, or kidney dysfunction. (2) No history of long-term use of immunosuppressants. 6. Informed consent: The patient or their legal representative signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Participated in other clinical trials within the past 3 months; 3.Having serious neurological disorders or mental disorders, unable to cooperate with research; 4.There is a tendency for active bleeding or other severe bleeding; 5.Suffering from malignant tumors or other end-stage diseases.

Design outcomes

Primary

MeasureTime frame
28-day patient survival rate;

Secondary

MeasureTime frame
Changes in SOFA score;ICU stay duration;Changes in lab test indicators (like CRP, PCT, etc.);

Countries

China

Contacts

Public ContactWang Zhigang

The First Affiliated Hospital, Jinan University

drwangzg@sina.com+86 20 38688362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026